Send PM
Followers 119
Posts 2381
Boards Moderated 1
Alias Born 12/27/2007

FREE
ETTX REPORT

Re: None

Tuesday, 06/16/2020 3:07:48 PM

Tuesday, June 16, 2020 3:07:48 PM

Post# of 19
(ETTX-DD) Low Valuation of $86 Million / STRONG Cash of $63 Million/ 2 attractive Drugs in late Phase 3 with LARGE market potential with first readout within 6-7 months / Insider & Institutional investors holding most of the shares /Low float stock = $15-20 stock here on this undiscovered biotech gem .GL


Presentation June
https://investors.entasistx.com/static-files/0bf75506-2d54-4b14-896a-6a3d5ed53472

Major Shareholders

Innoviva Inc...14M
Novo Holdings A/S...2.2M
AstraZeneca PLC...2.2M
Clarus Ventures, LLC...1.6M
Pivotal ...1.2M
Sofinnova ...1.2M
Frazier ...1.0M
TPG Capital, L.P...1.0M
Eventide Asset ...879.5K
Granahan ...154.7K